SPOROLIFE
LIVE

Serial Number

88534786

Owner

Kenrico Ltd.

Attorney

Joseph A. Mandour

First Use Date

Jan 5, 2017

Filing Date

Jul 25, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SPOROLIFE Trademark

Serial Number: 88534786 • Registration: 5982682

SPOROLIFE is a trademark filed by Kenrico Ltd. on July 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Kenrico Ltd. (31 trademarks)

1738-2 Kikugawa
Shimada 428-0037 , JP

Entity Type: 03

Trademark Details

Filing Date

July 25, 2019

Registration Date

February 11, 2020

First Use Anywhere

January 5, 2017

First Use in Commerce

January 5, 2017

Published for Opposition

November 26, 2019

Goods & Services

Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for use in dermatology; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 11, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 11, 2025 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Mar 5, 2025 EROP
OFFICE ACTION ISSUED POU1
Mar 4, 2025 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 3, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 12, 2025 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 11, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 26, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 26, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 6, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 24, 2019 CNSA
ASSIGNED TO EXAMINER
Oct 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 2, 2019 NWOS
NEW APPLICATION ENTERED
Jul 29, 2019 NWAP